Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04949191 |
Title | The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies. |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Incyte Corporation |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | DNK |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
John Wayne Cancer Institute | Santa Monica | California | 90404 | United States | Details | |
Oncology Specialists of Charlotte | Charlotte | North Carolina | 28207 | United States | Details | |
Md Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | United States | Details | |
Virginia Cancer Specialists, Pc | Fairfax | Virginia | 22031 | United States | Details | |
The Finsen Centre National Hospital | Copenhagen | 02100 | Denmark | Details | ||
Fondazione Irccs Istituto Nazionale Dei Tumori | Milan | 20133 | Italy | Details | ||
Istituto Nazionale Tumori Regina Elena Irccs | Rome | 00144 | Italy | Details | ||
Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria Alle Scotte | Siena | 53100 | Italy | Details | ||
Kanagawa Cancer Center | Yokohama-Shi | 241-8515 | Japan | Details |